BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2403526)

  • 1. Inhibition of intraerythrocytic development of Plasmodium falciparum by proteinase inhibitors.
    Rockett KA; Playfair JH; Ashall F; Targett GA; Angliker H; Shaw E
    FEBS Lett; 1990 Jan; 259(2):257-9. PubMed ID: 2403526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria.
    Rosenthal PJ; Lee GK; Smith RE
    J Clin Invest; 1993 Mar; 91(3):1052-6. PubMed ID: 8450035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of three stage-specific proteinases of Plasmodium falciparum.
    Rosenthal PJ; Kim K; McKerrow JH; Leech JH
    J Exp Med; 1987 Sep; 166(3):816-21. PubMed ID: 3305763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metalloprotease inhibitors on invasion of red blood cell by Plasmodium falciparum.
    Kitjaroentham A; Suthiphongchai T; Wilairat P
    Acta Trop; 2006 Jan; 97(1):5-9. PubMed ID: 16168946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arresting malaria parasite egress from infected red blood cells.
    Lee MC; Fidock DA
    Nat Chem Biol; 2008 Mar; 4(3):161-2. PubMed ID: 18277974
    [No Abstract]   [Full Text] [Related]  

  • 6. Peptide derivatives specific for a Plasmodium falciparum proteinase inhibit the human erythrocyte invasion by merozoites.
    Mayer R; Picard I; Lawton P; Grellier P; Barrault C; Monsigny M; Schrével J
    J Med Chem; 1991 Oct; 34(10):3029-35. PubMed ID: 1920353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parasite proteases and antimalarial activities of protease inhibitors.
    Vander Jagt DL; Caughey WS; Campos NM; Hunsaker LA; Zanner MA
    Prog Clin Biol Res; 1989; 313():105-18. PubMed ID: 2675111
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression and characterisation of plasmepsin I from Plasmodium falciparum.
    Moon RP; Tyas L; Certa U; Rupp K; Bur D; Jacquet C; Matile H; Loetscher H; Grueninger-Leitch F; Kay J; Dunn BM; Berry C; Ridley RG
    Eur J Biochem; 1997 Mar; 244(2):552-60. PubMed ID: 9119023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the in vitro growth of Plasmodium falciparum by D vitamins and vitamin D-3 derivatives.
    Vial HJ; Thuet MJ; Philippot JR
    Mol Biochem Parasitol; 1982 Mar; 5(3):189-98. PubMed ID: 6283344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Plasmodium activity of ceramide analogs.
    Labaied M; Dagan A; Dellinger M; Gèze M; Egée S; Thomas SL; Wang C; Gatt S; Grellier P
    Malar J; 2004 Dec; 3():49. PubMed ID: 15588325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calpain inhibitors on the invasion of human erythrocytes by the parasite Plasmodium falciparum.
    Olaya P; Wasserman M
    Biochim Biophys Acta; 1991 Apr; 1096(3):217-21. PubMed ID: 2018795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development.
    Korde R; Bhardwaj A; Singh R; Srivastava A; Chauhan VS; Bhatnagar RK; Malhotra P
    J Med Chem; 2008 Jun; 51(11):3116-23. PubMed ID: 18461922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of eryptosis and intraerythrocytic growth of Plasmodium falciparum by flufenamic acid.
    Kasinathan RS; Föller M; Koka S; Huber SM; Lang F
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):255-64. PubMed ID: 17180616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of the efficiency of fatty acid derivatives in suppressing Plasmodium falciparum growth in culture with their inhibitory effect on acyl-CoA synthetase activity.
    Beaumelle BD; Vial HJ
    Mol Biochem Parasitol; 1988 Feb; 28(1):39-42. PubMed ID: 3287157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical and thermal inhibition of protein secretion have stage specific effects on the intraerythrocytic development of Plasmodium falciparum in vitro.
    Benting J; Ansorge I; Paprotka K; Lingelbach KR
    Trop Med Parasitol; 1994 Dec; 45(4):303-7. PubMed ID: 7716392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d.
    Eksi S; Czesny B; van Gemert GJ; Sauerwein RW; Eling W; Williamson KC
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1064-70. PubMed ID: 17178799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Griseofulvin impairs intraerythrocytic growth of Plasmodium falciparum through ferrochelatase inhibition but lacks activity in an experimental human infection study.
    Smith CM; Jerkovic A; Truong TT; Foote SJ; McCarthy JS; McMorran BJ
    Sci Rep; 2017 Feb; 7():41975. PubMed ID: 28176804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites.
    Rosenthal PJ
    Exp Parasitol; 1995 Mar; 80(2):272-81. PubMed ID: 7895837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of P. falciparum dipeptidyl aminopeptidase 3 specificity identifies differences in amino acid preferences between peptide-based substrates and covalent inhibitors.
    de Vries LE; Sanchez MI; Groborz K; Kuppens L; Poreba M; Lehmann C; Nevins N; Withers-Martinez C; Hirst DJ; Yuan F; Arastu-Kapur S; Horn M; Mares M; Bogyo M; Drag M; Deu E
    FEBS J; 2019 Oct; 286(20):3998-4023. PubMed ID: 31177613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Looking for the exit: How do malaria parasites escape from red blood cells?
    Bannister LH
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):383-4. PubMed ID: 11209038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.